By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – DNA Genotek announced today that it has field for US Food and Drug Administration clearance of its Oragene Dx family of products.

The Oragene products are used to collect DNA samples from saliva and for isolating and stabilizing DNA for transport and storage.

"We believe that the successful completion of this 510(k) clearance will facilitate broad use of Oragene Dx in molecular diagnostics," DNA Genotek President and CEO Ian Curry said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.